NVWM LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.85M | Sell |
11,341
-920
| -8% | -$198K | 0.58% | 48 |
|
|
2026
Q1 | $2.67M | Buy |
12,261
+7
| +0.1% | +$1.55K | 0.59% | 43 |
|
|
2025
Q4 | $2.8M | Sell |
12,254
-130
| -1% | -$29.6K | 0.61% | 43 |
|
|
2025
Q3 | $2.87M | Sell |
12,384
-79
| -0.6% | -$16.1K | 0.64% | 39 |
|
|
2025
Q2 | $2.31M | Buy |
12,463
+612
| +5% | +$114K | 0.56% | 46 |
|
|
2025
Q1 | $2.48M | Sell |
11,851
-468
| -4% | -$91K | 0.66% | 39 |
|
|
2024
Q4 | $2.19M | Buy |
12,319
+149
| +1% | +$27.4K | 0.55% | 44 |
|
|
2024
Q3 | $2.4M | Sell |
12,170
-146
| -1% | -$27.2K | 0.61% | 39 |
|
|
2024
Q2 | $2.11M | Buy |
12,316
+1,719
| +16% | +$285K | 0.56% | 45 |
|
|
2024
Q1 | $1.93M | Sell |
10,597
-177
| -2% | -$30.5K | 0.53% | 54 |
|
|
2023
Q4 | $1.67M | Sell |
10,774
-2,889
| -21% | -$421K | 0.5% | 54 |
|
|
2023
Q3 | $2.04M | Buy |
13,663
+15
| +0.1% | +$2.2K | 0.67% | 48 |
|
|
2023
Q2 | $1.84M | Sell |
13,648
-7,109
| -34% | -$1.04M | 0.6% | 48 |
|
|
2023
Q1 | $3.31M | Buy |
20,757
+271
| +1% | +$41.4K | 1.11% | 14 |
|
|
2022
Q4 | $3.31M | Sell |
20,486
-211
| -1% | -$32.4K | 1.2% | 14 |
|
|
2022
Q3 | $2.78M | Buy |
20,697
+5,167
| +33% | +$741K | 1.1% | 11 |
|
|
2022
Q2 | $2.38M | Buy |
15,530
+259
| +2% | +$39.6K | 0.92% | 19 |
|
|
2022
Q1 | $2.48M | Sell |
15,271
-4,996
| -25% | -$726K | 0.78% | 30 |
|
|
2021
Q4 | $2.74M | Sell |
20,267
-4
| -0% | -$473 | 0.85% | 27 |
|
|
2021
Q3 | $2.19M | Buy |
20,271
+485
| +2% | +$55.4K | 0.79% | 30 |
|
|
2021
Q2 | $2.23M | Sell |
19,786
-263
| -1% | -$29.6K | 0.8% | 31 |
|
|
2021
Q1 | $2.17M | Buy |
20,049
+952
| +5% | +$102K | 0.86% | 31 |
|
|
2020
Q4 | $2.05M | Buy |
19,097
+222
| +1% | +$21.3K | 0.85% | 33 |
|
|
2020
Q3 | $1.65M | Buy |
18,875
+584
| +3% | +$55K | 0.78% | 38 |
|
|
2020
Q2 | $1.8M | Buy |
18,291
+16,202
| +776% | +$1.43M | 0.97% | 29 |
|
|
2020
Q1 | $159K | Buy |
2,089
+764
| +58% | +$65.1K | 0.11% | 137 |
|
|
2019
Q4 | $117K | Hold |
1,325
| – | – | 0.07% | 149 |
|
|
2019
Q3 | $100K | Buy |
+1,325
| New | +$90.8K | 0.06% | 164 |
|
|
2019
Q1 | – | Sell |
-350
| Closed | -$32K | – | 336 |
|
|
2018
Q4 | $32K | Sell |
350
-27
| -7% | -$2.37K | 0.02% | 195 |
|
|
2018
Q3 | $36K | Sell |
377
-5,332
| -93% | -$506K | 0.02% | 192 |
|
|
2018
Q2 | $529K | Buy |
5,709
+80
| +1% | +$7.81K | 0.37% | 88 |
|
|
2018
Q1 | $514K | Buy |
5,629
+5,266
| +1,451% | +$578K | 0.37% | 90 |
|
|
2017
Q4 | $35K | Buy |
+363
| New | +$34.2K | 0.03% | 187 |
|
Other funds holding ABBV
NVWM LLC's ABBV Position: Q2 2026 in Review
NVWM LLC reduced its AbbVie (ABBV) stake by 7.5% in Q2 2026, selling an estimated $198K and leaving 11,341 shares worth $2.85M. The position accounts for 0.58% of the portfolio, ranked #48.
NVWM LLC first reported a position in ABBV in Q4 2017 and has held it in 33 quarters since. The position peaked at $3.31M in Q4 2022. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- NVWM LLC held 11,341 shares of AbbVie worth $2.85M as of Q2 2026.
- NVWM LLC sold 920 AbbVie shares in Q2 2026, an estimated $198K.
- AbbVie made up 0.58% of NVWM LLC's portfolio in Q2 2026, its #48 holding.
- NVWM LLC first reported a position in AbbVie in Q4 2017 and has held it in 33 quarters since.
- NVWM LLC's AbbVie position peaked at $3.31M in Q4 2022.
- 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.